Protein Summary
Binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate and folate analogs into the interior of cells. Has high affinity for folate and folic acid analogs at neutral pH. Exposure to slightly acidic pH after receptor endocytosis triggers a conformation change that strongly reduces its affinity for folates and mediates their release. Required for normal embryonic development and normal cell proliferation. The protein encoded by this gene is a member of the folate receptor family. Members of this gene family bind folic acid and its reduced derivatives, and transport 5-methyltetrahydrofolate into cells. This gene product is a secreted protein that either anchors to membranes via a glycosyl-phosphatidylinositol linkage or exists in a soluble form. Mutations in this gene have been associated with neurodegeneration due to cerebral folate transport deficiency. Due to the presence of two promoters, multiple transcription start sites, and alternative ...more
- ENST00000312293
- ENSP00000308137
- ENSG00000110195
- ENST00000393676
- ENSP00000377281
- ENST00000393679
- ENSP00000377284
- ENST00000393681
- ENSP00000377286
- FOLR
- FBP
- FOLR
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
PubMedID | 0.82 | ||
transcription factor perturbation | 0.8 | ||
disease perturbation | 0.79 | ||
gene perturbation | 0.77 | ||
small molecule perturbation | 0.77 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 416.76 (req: < 5)
Gene RIFs: 117 (req: <= 3)
Antibodies: 432 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 416.76 (req: >= 5)
Gene RIFs: 117 (req: > 3)
Antibodies: 432 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 20
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 56
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drugs: 5